HBW Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
Germany Health OTC Drugs

Clean Sweep For German Rx-To-OTC Switches Of Next-Gen Pain And Cough Treatments

Executive Summary

Germany’s Expert Committee for Prescription has recommended three novel Rx-to-OTC switch applications: analgesics dexibuprofen and ibuprofen/paracetamol single-pill combinations, and cough treatment levodropropizine.

You may also be interested in...



Next Generation OTC Painkillers And Cough Syrup On Cards For German Switch Committee

Rx-to-OTC switches of the painkillers dexibuprofen and single-pill combinations of ibuprofen and paracetamol as well as the cough medicine levodropropizine, all for oral use, will be considered at the next German Expert Committee for Prescription meeting on 13 July.

Hungary Reverse-Switches High-Dose Ibuprofen

OTC ibuprofen products marketed by Sanofi, Mylan and Zambon among those reverse-switched to Rx status by Hungary's drug regulator.

ADM Protexin Launches Vitamin-Enriched Probiotic, Investigates Gut-Brain Axis

To help brighten up summer for UK consumers,  ADM Protexin has added a vitamin-enriched food supplement to its Bio-Kult line of probiotics. The firm also profiles a recent clinical trial showing promise for probiotic-related mood improvement in a short documentary. 

Table

View full table

Topics

Tags:
Germany Health OTC Drugs
UsernamePublicRestriction

Register

RS151572

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By